About

Founded

2015

Headquarters

San Mateo, California

Industry

Healthcare, Biotech

Company Description

Helix is the leading population genomics and viral surveillance company. Helix enables health systems, public health organizations and life science companies to accelerate the integration of genomic data into patient care and public health decision making.

Quick Links

Website Jobs

Funding

Total Raised

$403 million

Valuation

Undisclosed

Significant Investors

Mayo Clinic, Temasek, Kleiner Perkins, Warburg Pincus, DFJ Growth

Company Traction

As of June 2021, Helix sequences ~20,000 protein-coding genes and 300,000 informative non-coding regions to create robust genomic profiles.

Leadership Team

James Lu: Co-Founder & CEO of Helix. Former Associate in Research at Duke University.

Jim Chou: CTO at Helix. Former VP of Engineering at Practice Fusion.

William Lee: SVP, Chief Science Officer at Helix. Former Senior Research Scientist at Memorial Sloan-Kettering Cancer Center.

Sarah Bobulsky: CFO at Helix. Former VP at EY.

Sheren Chiang: VP of People at Helix. Former VP of People at Favor.

Press

The Quint (August 31, 2022): India, UK Based Biotech Company Anuva Partners With US Genomics Giant

FinSMEs (June 4, 2021): Helix Raises $50M in Series C Funding

Helix